--

Additional Metadata
Keywords 0 (Fibrinolytic Agents), 21829-25-4 (Nifedipine), 55-63-0 (Nitroglycerin), Adult, Clinical Trials, Coronary Vessels, EC 3.4.- (Streptokinase), EC 3.4.21.73 (Urinary Plasminogen Activator), Fibrinolysis, Fibrinolytic Agents/administration & dosage/*therapeutic use, Heart Catheterization, Human, Male, Middle Aged, Myocardial Infarction/*drug therapy, Nifedipine/therapeutic use, Nitroglycerin/therapeutic use, Pilot Projects, Random Allocation, Risk, Streptokinase/administration & dosage/therapeutic use, Urinary Plasminogen Activator/administration & dosage/therapeutic use
Persistent URL hdl.handle.net/1765/4063
Citation
Serruys, P.W.J.C., van den Brand, M.J.B.M., Hooghoudt, T.E.H., Simoons, M.L., Fioretti, P.M., Ruiter, J., … Hugenholtz, P.G.. (1982). Coronary recanalization in acute myocardial infarction: immediate results and potential risks. European Heart Journal, 3, 404–415. Retrieved from http://hdl.handle.net/1765/4063